Leber hereditary optic neuropathy's (LHON) cause could be identfiied soon, according to a study done by the researchers at McGill University which was published in the journal Scientific Reports.
Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field. Due to the founder effect from the filles du roi, there is a disproportionate preponderance of a particular LHON mutation among the French-Canadian population.
Gene Therapy to treat Leber Congenital Amaurosis, Improves Retinal Sensitivity in Weeks
It has improved vision in previously untreatable and incurable retinal conditions of LCA, which is an inherited disorder that caused blindness in childhood.
Advertisement
‘Identifying the accurate role of superoxide in spreading the damage among cells could aid to develop a proper treatment for LHON.’
Read More..
Tweet it Now
Read More..
The researchers had previously showed that the cells that connect the eye to the brain were sensitive to a certain free radical, known as "superoxide," and hypothesized that the presence of too much superoxide was likely the cause of LHON.
Until recently, researchers believed the cause of LHON was related to the size of the fibers that connect the eye to the brain, with small fibers being more sensitive. However, it wasn't clear how exactly the two were connected.
"We speculated that superoxide spreading among the fibers of those cells was the cause of the specific clinical features of LHON. We realized that we could test this hypothesis by computer simulation," explains Dr. Leonard Levin, Chair of the Department of Ophthalmology and Visual Sciences at McGill University's Faculty of Medicine and the paper's senior author.
Dr. Levin collaborated with Dr. Razek Coussa, who did the work while a resident in the Department of Ophthalmology and Visual Sciences, and Pooya Merat, a PhD candidate in the Department of Electrical and Computer Engineering at McGill, who provided the computing power needed to render the simulations possible. To validate their findings, the team compared the results of their simulations to pathology specimens and visual fields from patients acquired through colleagues at UCLA, and the researchers were surprised by how well the two were aligned.
While this finding represents an important step, Dr. Levin notes that work remains to be done. "We need to confirm the role of superoxide in spreading the damage in actual cells. If we can do so, this could go a long way towards helping us develop a treatment for LHON."
Source: Eurekalert
Advertisement
"We speculated that superoxide spreading among the fibers of those cells was the cause of the specific clinical features of LHON. We realized that we could test this hypothesis by computer simulation," explains Dr. Leonard Levin, Chair of the Department of Ophthalmology and Visual Sciences at McGill University's Faculty of Medicine and the paper's senior author.
Dr. Levin collaborated with Dr. Razek Coussa, who did the work while a resident in the Department of Ophthalmology and Visual Sciences, and Pooya Merat, a PhD candidate in the Department of Electrical and Computer Engineering at McGill, who provided the computing power needed to render the simulations possible. To validate their findings, the team compared the results of their simulations to pathology specimens and visual fields from patients acquired through colleagues at UCLA, and the researchers were surprised by how well the two were aligned.
While this finding represents an important step, Dr. Levin notes that work remains to be done. "We need to confirm the role of superoxide in spreading the damage in actual cells. If we can do so, this could go a long way towards helping us develop a treatment for LHON."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.